A Wearable Continuous Immune Monitor: Shana Kelley on The Long Run
Shana Kelley is today’s guest on The Long Run.
Shana is a professor of chemistry at Northwestern University and the president of the Chan Zuckerberg Biohub in Chicago.

Shana Kelley, professor of chemistry, Northwestern University; president, Chan Zuckerberg Biohub Chicago
One of the cool projects she oversees is for a continuous wearable immune monitor. It’s inspired by continuous glucose monitors that have changed the way diabetes is treated and managed. No such device exists today for continuous tracking of inflammation. If her team of chemists, biologists and engineers can pull this off, it would have big implications for research and treatment of immune disorders that affect millions of people.
The detection of inflammatory proteins was demonstrated in mice and published in Science in December 2024. The next steps to build something suitable for the marketplace will require some kind of industry partnership.
Shana, like a lot of scientists, has taken a circuitous path. I enjoyed hearing her story of how she got to this moment of possibility to seize on new technology tools, and growing knowledge of biology, to spearhead a project with such potential for human health.
The Long Run is sponsored by

Anyone who’s tried to stay current on a fast-moving therapeutic area knows the real problem isn’t finding information — it’s that there’s too much of it, and it changes every week.
AlphaSense just launched SuperAnalyst, an always-on agent that works like a power user inside the platform on your behalf. It draws on AlphaSense’s full life sciences content universe — clinical trial data, peer-reviewed literature, regulatory filings, conference presentations, and expert transcripts with researchers, clinicians, and executives — and it keeps monitoring your space even after you’ve closed your laptop.
It’s designed to act like an extension of your research team. It remembers the programs and competitors you’re tracking, follows your process, and applies it automatically to new data as it comes in. And every output links back to its original source, so when you’re citing a trial result you can see exactly where the number came from.
Take the task you’ve been meaning to get to — tracking a competitor’s trial program or flagging the next regulatory decision before it hits— and hand it to SuperAnalyst.
Start your free trial at alpha-sense.com/TheLongRun.
AND
Quick question: when was the last time a CRO told you what something costs before you signed an NDA, sat through two scoping calls, and waited a week for a Scope of Work? In bioanalysis, pricing gets treated like a closely-guarded secret. Dash Bio thinks that’s backward. It publishes pricing publicly, on its website, and even has a calculator that shows how the price changes if you redesign your study. You can see what your study costs before you talk to a human being. No surprise line items, no “it depends”, no games. Dash was built to be the bioanalysis company that’s actually straightforward to work with: transparent pricing, guaranteed timelines, and data in days, not months.
If you’re tired of pricing that feels like a negotiation every single time, run your bioanalysis with Dash. Visit dash.bio/pricing and see exactly how much your next bioanalysis study will cost.

Now please enjoy this conversation with Shana Kelley on The Long Run.


